1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   
   
3. Who will be able to view these files?
   Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [dr.mnroopa@gmail.com].
   


6. For how long will this data be available start date provided 01-01-2026 and end date provided 01-01-2028?
   Response - Beginning 9 months and ending 36 months following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - Nil

Living donor liver transplantation (LDLT) is an established treatment modality for end-stage liver disease and it alleviates the shortage of cadaveric donor organs. Donor safety during the perioperative period is a major concern of LDLT. In general, hepatectomy causes a significant blood loss which is among the major causes of post-operative morbidity and mortality. Any strategy to reduce blood loss during hepatectomy is important and various surgical and anaesthetic methods have been reported. Although low central venous pressure technique can still be effective, it may not be advantageous concerning the safety of healthy donors undergoing hepatectomy. Emerging evidence suggests that stroke volume variation, a simple and useful index for fluid responsiveness and preload status in various clinical situations, can be applied as a guide for fluid management to reduce blood loss during living donor hepatectomy. Most hemodynamic monitors used widely now are invasive, which may cause complications and bring discomfort to the patients. NICOM is an application of biological reactor technology, monitoring cardiac output, cardiac index, stroke volume, stroke volume variability and other hemodynamic parameters by analysing electric pulses through the frequency change of chest.